AvantiCell Science specialises in the isolation and culture of human primary cells for use in preclinical drug development and in vitro testing of materials ranging from natural therapeutics to traditional medicines, food components and medical devices. The company offers an alternative to animal testing: human primary cells isolated from ethically-sourced tissue, when cultured under appropriate conditions, deliver analytical predictive value i.e. results likely to indicate...
The new £44 million facility at GSK Montrose will provide ingredients for over 400 million vaccinations a year. Significant investment in recent years re-affirms GSK’s belief that Scotland is an excellent base to manufacture and export to global markets. Built at a cost of £44M, the new facility at GSK’s site at Montrose in north-east Scotland will manufacture sterile aluminium salts which are compounds that...
Innovation & “a very different way of thinking” is at the core of NovaBiotics & the reason for our success; combating antimicrobial resistance (AMR) by developing first-in-class new medicines for medically unmet, socioeconomically significant infections We specialise in unconventional ‘Smart Immunology’ based approaches to tackling infection and in doing so have engineered antifungal and antibacterial drug candidates with the potential to revolutionise the anti-infective industry....
Providing specialised high containment biopharmaceutical facilities to enable high potency and cytotoxic drugs to be handled during drug product development and manufacture here in Scotland. Capsugel’s facility in Livingston, Scotland (formerly Encap Drug Delivery) was founded in 1989 by a Scottish Entrepreneur and later acquired by Capsugel in 2013 due to a combination of its specialised expertise in high containment, its highly skilled and well...
Providing specialist services for the improved prediction of drug safety and efficacy using human tissue based models of drug activity. REPROCELL’s Centre for Predictive Drug Discovery was officially opened by the First Minister, Nicola Sturgeon MSP on 9th August 2017. The Centre’s work continues over 15 years of successful delivery of preclinical contract research services by Biopta Ltd, a Glasgow company founded in 2002 and...